Skip to content

Outcome After Radial Pressure Wave Therapy in Plantar Fasciitis.

Exploratory Analysis of Pain and Function Improvement After Radial Pressure Wave Therapy in Plantar Fasciitis.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06813105
Acronym
RPWT
Enrollment
19
Registered
2025-02-06
Start date
2024-11-19
Completion date
2025-01-20
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fasciitis, Plantar, Fasciitis, Plantar, Chronic

Keywords

plantar fasciitis, rehabilitation outcomes

Brief summary

The goal of this observational study is to explore potential associations between baseline patient characteristics (such as age, body mass index, and baseline pain intensity) and clinical outcomes in patients with plantar fasciitis undergoing radial pressure wave therapy (RPWT). The study includes male and female adults aged 18 to 60 years.

Detailed description

Background: Plantar fasciitis (PF) is a common cause of heel pain, significantly impairing functionality and quality of life. Radial pressure wave therapy (RPWT) has emerged as a non-invasive therapeutic option. However, there is limited evidence regarding factors that may influence clinical outcomes in patients receiving this treatment. Objectives: The primary objective of this study is to explore potential associations between baseline patient characteristics (such as age, body mass index, and pain intensity) and clinical outcomes in patients with PF treated with RPWT. Additionally, this study aims to assess changes in pain intensity and functionality following RPWT. Materials and Methods: This is an exploratory, pilot observational study including patients diagnosed with PF who undergo three sessions of RPWT. The study evaluates changes in pain intensity, assessed using the Numerical Pain Rating Scale (NPRS), and functionality, measured using the WHODAS 2.0. Patient characteristics such as age, body mass index (BMI), and PF chronicity are collected retrospectively from medical records. Statistical analyses will be conducted to examine potential associations between patient characteristics and treatment outcomes.

Interventions

None listed

Sponsors

University of Guadalajara
CollaboratorOTHER
Hospital Civil de Guadalajara
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of plantar fasciitis confirmed by clinical evaluation. * Age 18 to 60 years. * Symptoms persisting for at least three months before treatment. * Completed three RPWT sessions using a standardized protocol (2000 impulses per session, 10 Hz, and 3.5 bar). * Availability of complete medical records, including three-month follow-up data.

Exclusion criteria

* History of foot surgery or corticosteroid injection in the affected limb within the past six months. * Pregnancy at the time of treatment. * Presence of concurrent musculoskeletal conditions (e.g., fractures, active infections, sprains) in the affected limb. * Diagnosis of systemic conditions (e.g., cancer, osteoporosis, autoimmune diseases). * Incomplete medical records or failure to complete RPWT sessions and follow-up visits.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity assessed by the Numerical Pain Rating Scale (NPRS).Immediately after the last RPWT session, approximately 1 week after baseline.Pain intensity will be measured using the Numerical Pain Rating Scale (NPRS), a validated 10-point scale where 0 represents no pain and 10 represents the worst pain imaginable.

Secondary

MeasureTime frameDescription
Functionality assessed by the WHODAS 2.0 scale.Immediately after the last RPWT session, approximately 1 week after baseline.Functionality will be evaluated using the WHODAS 2.0, a 12-item questionnaire assessing six domains of disability (cognition, mobility, self-care, interpersonal relationships, life activities, and community participation). Each item is rated on a 5-point scale, where higher scores indicate greater disability.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026